Hot penny stocks... don't get burned
Research Report
Matthew D. Linnik Ph.d. is a Chief Scientific Officer of La Jolla Pharmaceuticals. Hotstocked.com has a complete research report available for LJPC stock. Download LJPC report.
Research Report
Get the full report for FREE
Date:Sep 3, 2008
Price:Free
Pages:5
Document Type:Adobe Acrobat Reader
 Download LJPC report
  
Example preview: Research report for La Jolla Pharmaceuticals (LJPC) Research report for La Jolla Pharmaceuticals (LJPC) Research report for La Jolla Pharmaceuticals (LJPC) Research report for La Jolla Pharmaceuticals (LJPC)
   

Matthew D. Linnik Ph.d.

Rate this Executive:
Not rated yet Not rated yet.
This is a page dedicated to get more information for investors to evaluate the management style of Matthew D. Linnik Ph.d. who is a Chief Scientific Officer of La Jolla Pharmaceuticals.

Here on this page we are inviting all readers to discuss Matthew D. Linnik Ph.d.. You may anonymously post comments with any information that they have about Matthew D. Linnik Ph.d.. You can post comments about their management style or whatever you want to talk about concerning their ability as an executive. Please refrain from personal attacks.

User comments


Type the characters that you see in the box (5 characters).

This is a captcha-picture. It is used to prevent mass-access by robots. (see: www.captcha.net)

  

I would like to be notified by e-mail if someone comments on this page. Email confirmation needed. Privacy Statement.
   
   
   
   
Here is a copy of personal Bio that we found:
Name: Matthew D. Linnik Ph.d.
Age: 48
« Martin A. Kits Van Heyningen Michael L. Kubacki »
   
   
Company name Officer position Pay Exercised
La Jolla Pharmaceuticals Chief Scientific Officer, Exec. VP of Research and Assistant Sec. $ 468.00K $ 0
   
 
Home > Officers > Matthew D. Linnik Ph.d.